| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/17/2007 | CA2556287A1 Methods of treatment using vascular occlusion in combination with one or more therapies |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019344A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | WO2007018475A1 Novel anticoagulant polypeptides and complex |
| 02/15/2007 | WO2007018437A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007017154A2 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 02/15/2007 | WO2006111285A3 Imino-oxazolidines and use thereof as anticoagulants |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037842 Polymorphs and amorphous form of (s)-(+)-clopidogrel bisulfate |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037814 ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa |
| 02/15/2007 | US20070037813 Serine Protease Inhibitors |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070037749 Administering a N-terminus modified polypeptide derived from the fibrin alpha or beta chain; antiinflammatory agent, anticoagulants; transplant rejection; arteriosclerosis |
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036747 Pharmaceutical combination useful for stem cell mobilization |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2618368A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | CA2618360A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2617557A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | CA2617532A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | CA2616902A1 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752446A2 Compounds for modulating cell proliferation |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1752143A1 Novel uses for drugs targeting glutamine synthetase |
| 02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343523B1 Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1242452B1 Chimeric natriuretic peptides |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | CN1914184A Urea derivatives |
| 02/14/2007 | CN1914149A Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events |
| 02/14/2007 | CN1913909A Composition for inhibiting thrombosis |
| 02/14/2007 | CN1912115A Venomous snake thrombin sample enzyme modified by polyethylene glycol |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911431A Decoction for treating gravid dropsy of deficiency of the kidney type, and its prpen. method |
| 02/14/2007 | CN1911392A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911387A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911386A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911383A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911382A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911381A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911377A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911376A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911374A Injection contg. traditional Chinese medicine, and its pren. method |
| 02/14/2007 | CN1911373A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911372A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911368A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911363A Decoction for treating deficiency of live-yin and kidney-yin type aplastic anemia, and its prepn. method |
| 02/14/2007 | CN1911342A Decoction for treating blood dripping type uterine bleeding, and its prepn. method |
| 02/14/2007 | CN1911326A Oral medicine contg. donkey-hide gelatin and iron, and its prepn. method |
| 02/14/2007 | CN1911323A Decoction of herbal medicine for treating hemorrhagic type aplastic anemia, and its prepn. method |
| 02/14/2007 | CN1911321A Decoction of herbal medicine for treating damp-heat type aplastic anemia and preparation method |
| 02/14/2007 | CN1911318A Decoction of herbal medicine for treating insufficiency of both the spleen and the kidney type aplastic anemia, and its prepn. method |
| 02/14/2007 | CN1911317A Decoctior of herbal medicine for treating heat-toxin and flaming type aplastic anemia and its prepn. method |
| 02/14/2007 | CN1911298A Traditional Chinese medicine decoction for treating deficiency of vital energy type hepatocirrhosis hydroperitoneu, and its prepn. method |
| 02/14/2007 | CN1911280A Hemostatic medicine used for cavitas uteri |
| 02/14/2007 | CN1911277A Medicine for treating leukopenia |
| 02/14/2007 | CN1911250A Traditional Chinese medicine enteric oral liquor using leech extractive as active component, and its preparation method |
| 02/14/2007 | CN1911230A Cancer treatment |
| 02/14/2007 | CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 02/14/2007 | CN1911219A Medicine composition, and its application for treating diseases of cardiovascular and cerebrovascular |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1299708C Composite Chinese medicine for nourishing qi, restoring yang, replenishing vital essence and generating blood and its production |
| 02/14/2007 | CN1299698C Use of salivary gland secreta of cyclostomata in preparing medicines |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/14/2007 | CN1299670C Soft capsules for eliminating embolism and their preparation |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176283 Protease-activated receptor 3 and uses thereof |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |